Core Viewpoint - H. B. Fuller reported quarterly earnings of $1.26 per share, exceeding the Zacks Consensus Estimate of $1.24 per share, and showing an increase from $1.13 per share a year ago, indicating a positive earnings surprise of +1.61% [1] Financial Performance - The company achieved revenues of $892.04 million for the quarter ended August 2025, slightly surpassing the Zacks Consensus Estimate by 0.01%, but down from $917.93 million in the same quarter last year [2] - Over the last four quarters, H. B. Fuller has exceeded consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Performance - H. B. Fuller shares have declined approximately 11.7% since the beginning of the year, contrasting with the S&P 500's gain of 13.2% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.26 on revenues of $905.37 million, and for the current fiscal year, it is $4.18 on revenues of $3.48 billion [7] - The outlook for the Chemical - Specialty industry, where H. B. Fuller operates, is currently in the bottom 32% of over 250 Zacks industries, which may impact the stock's performance [8]

Company Performance - H. B. Fuller reported quarterly earnings of $1.18 per share, exceeding the Zacks Consensus Estimate of $1.1 per share, and showing an increase from $1.12 per share a year ago, resulting in an earnings surprise of +7.27% [1] - The company posted revenues of $898.1 million for the quarter ended May 2025, slightly surpassing the Zacks Consensus Estimate by 0.01%, but down from $917.11 million year-over-year [2] - Over the last four quarters, H. B. Fuller has surpassed consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Outlook - H. B. Fuller shares have declined approximately 15.7% since the beginning of the year, contrasting with the S&P 500's gain of 3.6% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is $1.22 on revenues of $894.11 million, and for the current fiscal year, it is $4.13 on revenues of $3.5 billion [7] Industry Context - The Chemical - Specialty industry, to which H. B. Fuller belongs, is currently ranked in the bottom 32% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors or through tools like the Zacks Rank [5][6]